V013-2347 Screening compound: N-[(1-benzyl-1H-pyrrol-2-yl)methyl]-N-cyclohexyl-2-[N-(3-methoxypropyl)-1-phenylformamido]acetamide

V013-2347 Screening compound: N-[(1-benzyl-1H-pyrrol-2-yl)methyl]-N-cyclohexyl-2-[N-(3-methoxypropyl)-1-phenylformamido]acetamide
V013-2347 Screening compound: N-[(1-benzyl-1H-pyrrol-2-yl)methyl]-N-cyclohexyl-2-[N-(3-methoxypropyl)-1-phenylformamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V013-2347
N-[(1-benzyl-1H-pyrrol-2-yl)methyl]-N-cyclohexyl-2-[N-(3-methoxypropyl)-1-phenylformamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V013-2347

Molecular Formula

C31H39N3O3 (C31 H39 N3 O3)

Compound Name

N-[(1-benzyl-1H-pyrrol-2-yl)methyl]-N-cyclohexyl-2-[N-(3-methoxypropyl)-1-phenylformamido]acetamide

IUPAC name

N-[(1-benzyl-1H-pyrrol-2-yl)methyl]-N-cyclohexyl-2-[N-(3-methoxypropyl)-1-phenylformamido]acetamide

SMILES

COCCCN(CC(N(Cc1cccn1Cc1ccccc1)C1CCCCC1)=O)C(c1ccccc1)=O

InChI

InChI=1S/C31H39N3O3/c1-37-22-12-21-33(31(36)27-15-7-3-8-16-27)25-30(35)34(28-17-9-4-10-18-28)24-29-19-11-20-32(29)23-26-13-5-2-6-14-26/h2-3,5-8,11,13-16,19-20,28H,4,9-10,12,17-18,21-25H2,1H3

InChI Key

AEWAGMMISWDKGA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19731522

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

501.67

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.865

Distribution Coefficient, logD

4.865

Water Solubility, LogSw

-4.52

Polar Surface Area

41.769

Acid Dissociation Constant (pKa)

23.01

Base Dissociation Constant (pKb)

-0.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.90

V013-2347 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V013-2347 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V013-2347?
Check Price and Availability of V013-2347, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V013-2347 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V013-2347
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V013-2347
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V013-2347 available by request